Method development for quantification of the environmental neurotoxin annonacin in Rat plasma by UPLC-MS/MS and application to a pharmacokinetic study

被引:14
作者
Bonneau, Natacha [1 ]
Schmitz-Afonso, Isabelle [2 ]
Brunelle, Alain [2 ]
Touboul, David [2 ]
Champy, Pierre [1 ]
机构
[1] Univ Paris 11, Univ Paris Saclay, Lab Pharmacognosie Chim Subst Nat, UMR BioCIS CNRS, F-9290 Chatenay Malabry, France
[2] Univ Paris 11, Inst Chim Subst Nat, CNRS ICSN UPR2301, Labex LERMIT, F-91198 Gif Sur Yvette, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2015年 / 1004卷
关键词
Acetogenin; Annonaceae; Annonacin; Bioavailability; Rat plasma; UPLC-MS/MS; MITOCHONDRIAL COMPLEX-I; ASIMINA-TRILOBA FRUIT; ATYPICAL PARKINSONISM; MASS-SPECTROMETRY; ACETOGENINS; NEURODEGENERATION; GUADELOUPE; INHIBITORS; PRODUCTS; CANCER;
D O I
10.1016/j.jchromb.2015.09.039
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Annonacin is an environmental neurotoxin identified in the pulp of several fruits of the Annonaceae family (for example in Annona muricata, Asimina triloba), whose consumption was linked with the occurrence of sporadic atypical Parkinsonism with dementia. Pharmacokinetic parameters of this molecule are unknown. A method for its quantification in Rat plasma was developed, using its analogue annonacinone as an internal standard. Extraction from plasma was performed using ethylacetate with a good recovery. Quantification was performed by UPLC-MS/MS in SRM mode, based on the loss of the gamma-methyl-gamma-lactone (-112 amu) from the sodium-cationized species [M + Na](+) of both annonacin and internal standard. The limit of quantification was 0.25 ng/mL. Despite strong matrix effects, a good linearity was obtained over two distinct ranges 0.25-10 ng/mL and 10-100 ng/mL The intra- and inter-day precisions (RSD) were lower than 10%, while accuracy was within +/- 10%. This method was applied to a pharmacokinetic study in the Rat. After oral administration of 10 mg/kg annonacin, a C-max of 7.9 +/- 1.5 ng/mL was reached at T-max 0.25 h; T-1/2 was 4.8 +/- 0.7 h and apparent distribution volume was 387.9 +/- 64.6 L The bioavailability of annonacin was estimated to be 3.2 +/- 0.3% of the ingested dose. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 20 条
[1]  
Agence Francaise de Securite Sanitaire des Aliments, 2010, AV AG FRANC SEC SAN
[2]   Structural study of acetogenins by tandem mass spectrometry under high and low collision energy [J].
Allegrand, Julie ;
Touboul, David ;
Schmitz-Afonso, Isabelle ;
Guerineau, Vincent ;
Giuliani, Alexandre ;
Le Ven, Jessica ;
Champy, Pierre ;
Laprevote, Olivier .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2010, 24 (24) :3602-3608
[3]   Acetogenins from Annonaceae:: recent progress in isolation, synthesis and mechanisms of action [J].
Bermejo, A ;
Figadère, B ;
Zafra-Polo, MC ;
Barrachina, I ;
Estornell, E ;
Cortes, D .
NATURAL PRODUCT REPORTS, 2005, 22 (02) :269-303
[4]   Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses [J].
Caparros-Lefebvre, D ;
Steele, J .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2005, 19 (03) :407-413
[5]   Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats:: possible relevance for atypical parkinsonism in Guadeloupe [J].
Champy, P ;
Höglinger, GU ;
Féger, J ;
Gleye, C ;
Hocquemiller, R ;
Laurens, A ;
Guerineau, V ;
Laprévote, O ;
Medja, F ;
Lombès, A ;
Michel, PP ;
Lannuzel, A ;
Hirsch, EC ;
Ruberg, M .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (01) :63-69
[6]  
Champy P., 2005, MOVEMENT DISORD, V20, P893
[7]   MALDI-TOF MS Profiling of Annonaceous Acetogenins in Annona muricata Products for Human Consumption [J].
Champy, Pierre ;
Guerineau, Vincent ;
Laprevote, Olivier .
MOLECULES, 2009, 14 (12) :5235-5246
[8]   Determination of bullatacin in rat plasma by liquid chromatography-mass spectrometry [J].
Chen, Yong ;
Chen, Jian-wei ;
Liu, Shi-jia ;
Xu, Chun-lei ;
Xu, Hui-qing ;
Cai, Bao-chang ;
Li, Xiang ;
Ju, Wen-zheng .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 897 :94-97
[9]  
European Medicines Agency, 2022, Committee for Medicinal Products for Human Use, Guideline on Bioanalytical Method Validation
[10]  
Feng H.-Z., 2012, GASTROENTEROL RES PR, V2012